Company profilePharmaceutical#128 of 1,318 in Pakistan✓ No DRAP alerts

Maxitech Pharma (Pvt) Ltd.

Pharmaceutical company · 134 brands · 92 molecules

Ranked #18 of 35 companies in Anti-Acne Preparations

134 registered products 51 pharmaceutical brands 92 distinct molecules 0 DRAP alerts

Company overview

134
registered products
51
pharmaceutical brands
92
distinct molecules
11
therapeutic classes
0
DRAP alerts

Maxitech Pharma (Pvt) Ltd. is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 134 product registrations across 92 distinct molecules. It is the 128th largest registrant in Pakistan by product count, and ranks 18th of 35 in Anti-Acne Preparations. Its portfolio is concentrated in Anti-Acne Preparations and Skin Conditions. It has no DRAP recall, shortage or safety notices on record.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Products by Maxitech

108 products matched in our catalogue · showing 80 — each with its observed price and DRAP approved ceiling.

Antibiotics For Topical Use 1
Corticosteroid Combinations, Topical 1
Antimycotics Systemic Use 1

Price ceiling age

DRAP sets a maximum price per registration and revises it only on application. In a market with high inflation, an old ceiling erodes margin in real terms.

97
ceilings with an approval date
0
not revised in 2+ years
2026
oldest approval year
202697

Top molecules by brand count

Therapeutic classes

Anti-Acne Preparations · 2Skin Conditions · 2Corticosteroid Combinations, Topical · 2Corticosteroid, Plain · 2Other Dermatological Preparations · 2Antifungal For Dermatological · 1Antivirals For Systemic Use · 1Antibiotics For Topical Use · 1Anti-Infectives · 1Pain Management · 1Quinolone Antibacterials · 1

Conditions treated

Acne/Oral · 1Wounds/Burns/Infections · 1Fungal Infection · 1Hair Loss · 1Pain Killers · 1

Price band (DRAP official ceilings)

Registered products priced by source
DRAP-official141 products · Rs 12 – Rs 31,355.23
DVAGO5 products · Rs 339.72 – Rs 1,600
Servaid5 products · Rs 138 – Rs 2,450.1
Median across source: Rs 665

Regulatory record

No DRAP alerts on record

No recalls, shortage notices or safety alerts involving this company’s products appear in the DRAP alert feed we track. Median across all 1,318 mapped companies is zero — 1,165 of them also have a clean sheet.

Competitive set

Companies whose registered portfolio overlaps most with this one.

Portfolio whitespace

Molecules the closest competitors have registered and this company has not — the starting point for a launch shortlist.

BIO LABS (PVT) LTD. holds 109 molecules not in this portfolio
000 I.UAmlodipineAprepitantAremetherArtesunateAtorvastatin
Atco Pharma International (Pvt) Ltd holds 206 molecules not in this portfolio
Acetylsalicylic AcidAcyclovirAdapaleneAdapleneAlbuterolAminophylline
PEARL PHARMACEUTICALS holds 40 molecules not in this portfolio
AcitretinAcyclovirAmlodipineArtemether LumefantrineCefotaxime SodiumCeftriaxone Sodium

Get the full profile for Maxitech

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.